September 20 – 22, 2017 | San Diego, CA

Sheraton San Diego Marina

Bioanalytical Day

Bio-analysis is a rapidly evolving area in ADC drug development. Yet, it is also one of the most challenging due to the diversity of novel ADC technologies and lack of standardized industry bio-analysis processes.

Capturing lessons-learned and distilling the latest industry intelligence leading experts in this space will help you to effectively characterize your ADC program. This will enhance your chances of filing a successful IND and entering the clinic.

Attend the 2017 ADC Bioanalysis Day to:

  • Review analytical and bioanalytical techniques for preclinical ADC characterization
  • Understand why ADC drugs with similar exposure profiles have at times unexpected end points for toxicity & efficacy
  • Improve continuity of PK profile utilising different assays technologies
  • Confidently develop novel platform assays for new ADC technologies
  • Learn how to improve consistency of ADC PK profile between discovery and development
  • Develop assays based on informed data from analytics
  • Hear experiences in filing IND and feedback from regulatory agencies

Click here to be notified as soon as program is released